Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Heterologous liver perfusion in treatment of hepatic failure.

Literature DB >> 5318668

Heterologous liver perfusion in treatment of hepatic failure.

B Eiseman, D S Liem, F Raffucci.

Abstract

Entities: Disease

Mesh：

Year: 1965 PMID： 5318668 PMCID： PMC1476914 DOI： 10.1097/00000658-196509000-00003

Source DB: PubMed Journal: Ann Surg ISSN： 0003-4932 Impact factor: 12.969

× No keyword cloud information.

10 in total

1. FUNCTION OF THE EX-VIVO PIG LIVER PERFUSED WITH HUMAN BLOOD.

Authors: D S LIEM; T L WALTUCH; B EISEMAN
Journal: Surg Forum Date: 1964

2. THE TREATMENT OF EXPERIMENTAL HEPATIC COMA BY PARABIOTIC CROSS CIRCULATION.

Authors: R JOYEUSE; B IVANISEVIC; W P LONGMIRE; J V MALONEY
Journal: Surg Gynecol Obstet Date: 1963-08

3. THE REGULATION OF SOME SUGAR DEHYDROGENASES IN A PSEUDOMONAD.

Authors: A S HU; A L CLINE
Journal: Biochim Biophys Acta Date: 1964-11-08

4. Isolated liver perfusion for reducing blood ammonia.

Authors: B EISEMAN; P KNIPE; H A MCCOLL; M J ORLOFF
Journal: Arch Surg Date: 1961-09

5. The measurement of ammonia in whole blood, erythrocytes, and plasma.

Authors: D SELIGSON; K HIRAHARA
Journal: J Lab Clin Med Date: 1957-06

6. The use of a donor liver in experimental animals with elevated blood ammonia.

Authors: J J OTTO; J C PENDER; J H CLEARY; D M SENSENIG; C S WELCH
Journal: Surgery Date: 1958-02 Impact factor: 3.982

7. Studies on the effect of hydrocholeretic agents on hepatic excretory mechanisms.

Authors: D L COOK; C A LAWLER; D M GREEN
Journal: J Pharmacol Exp Ther Date: 1954-03 Impact factor: 4.030

8. Factors Affecting Hepatic Vascular Resistance in the Perfused Liver.

Authors: B Eiseman; P Knipe; Y Koh; L Normell; F C Spencer
Journal: Ann Surg Date: 1963-04 Impact factor: 12.969

9. A technique for repetitive and long-term human cross circulation.

Authors: J W Eschbach; R H Hutchings; B Meston; J M Burnell; B H Scribner
Journal: Trans Am Soc Artif Intern Organs Date: 1964

10. Studies in ammonia metabolism. I. Ammonia metabolism and glutamate therapy in hepatic coma.

Authors: B EISEMAN; W BAKEWELL; G CLARK
Journal: Am J Med Date: 1956-06 Impact factor: 4.965

10 in total

46 in total

Review 1. Extracorporeal perfusion for the treatment of acute liver failure.

Authors: H B Stockmann; C A Hiemstra; R L Marquet; J N IJzermans
Journal: Ann Surg Date: 2000-04 Impact factor: 12.969

2. Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction.

Authors: T E Starzl; C W Putnam; M Ishikawa; R Picache; B Husberg; C G Halgrimson; G Schroter; K A Porter
Journal: Ann N Y Acad Sci Date: 1975-04-25 Impact factor: 5.691

Review 3. Cell therapies for liver diseases.

Authors: Yue Yu; James E Fisher; Joseph B Lillegard; Brian Rodysill; Bruce Amiot; Scott L Nyberg
Journal: Liver Transpl Date: 2012-01 Impact factor: 5.799

Heterologous liver perfusion in treatment of hepatic failure.

1. FUNCTION OF THE EX-VIVO PIG LIVER PERFUSED WITH HUMAN BLOOD.

2. THE TREATMENT OF EXPERIMENTAL HEPATIC COMA BY PARABIOTIC CROSS CIRCULATION.

3. THE REGULATION OF SOME SUGAR DEHYDROGENASES IN A PSEUDOMONAD.

4. Isolated liver perfusion for reducing blood ammonia.

5. The measurement of ammonia in whole blood, erythrocytes, and plasma.

6. The use of a donor liver in experimental animals with elevated blood ammonia.

7. Studies on the effect of hydrocholeretic agents on hepatic excretory mechanisms.

8. Factors Affecting Hepatic Vascular Resistance in the Perfused Liver.

9. A technique for repetitive and long-term human cross circulation.

10. Studies in ammonia metabolism. I. Ammonia metabolism and glutamate therapy in hepatic coma.

Review 1. Extracorporeal perfusion for the treatment of acute liver failure.

2. Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction.

Review 3. Cell therapies for liver diseases.

Review 4. Artificial and bioartificial support systems for liver failure.

Review 5. Aspects of hepatic hypoxia: observations on the isolated, perfused pig liver.

Review 6. Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients.

7. Hepatic assist devices: will they ever be successful?

Review 8. Extracorporeal Liver Support in Patients with Acute Liver Failure.

9. New method of hepatocyte transplantation and extracorporeal liver support.

10. Fulminant liver failure: clinical and experimental study.